Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Neuroinformatics wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Molecular neuroscience wikipedia , lookup
Node of Ranvier wikipedia , lookup
Neuropsychopharmacology wikipedia , lookup
Synaptogenesis wikipedia , lookup
National Institute of Neurological Disorders and Stroke wikipedia , lookup
The University of Sheffield Faculty of Medicine, Dentistry & Health Department of Neuroscience Investigation of axonal transport defects in mutant LRRK2-related Parkinson’s disease Supervisor: Kurt De Vos Project: Mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease and may also cause sporadic Parkinson’s disease. How mutations in LRRK2 cause Parkinson’s disease is not known. Most axonal and synaptic components and organelles are synthesised in the cell body and transported into and through the axon to their site of action in a process called anterograde axonal transport. Signals originating at the synapse, and axonal proteins and organelles destined for autophagy are conveyed back to the cell body by retrograde axonal transport. The main mechanism to deliver axonal cargoes is microtubule-based fast axonal transport. Axonal transport is mediated by motor proteins that shuttle cargoes along the microtubules. Axons contain two types of microtubule-based molecular motors, kinesin and cytoplasmic dynein, which drive most anterograde and retrograde transport, respectively. We now know that axonal transport malfunctions in a number of neurodegenerative diseases including Parkinson’s disease. We also know that axonal transport malfunction is one of the earliest, and possibly the earliest defect in these diseases. Therefore, understanding how healthy axonal transport works and what causes it to malfunction in these diseases is very important and is likely to reveal novel drug targets that may be developed into medicines aimed at sufferers from these diseases. This project is part of our on-going research into the molecular mechanisms underlying neurodegenerative diseases and will focus on the role of axonal transport in Parkinson’s Disease-related neurodegeneration. We will investigate if mutations in LRRK2 disrupt axonal transport and determine the underlying molecular mechanism. This research will involve techniques such as advanced quantitative microscopy including time-lapse and confocal fluorescence microscopy of mitochondrial and vesicle dynamics and transport, siRNA technology, western blotting and recombinant DNA technology. Entry Requirements: Candidates must have a first or upper second class honors degree or significant research experience. Enquiries: Interested candidates ([email protected]). should in the first instance contact Kurt De Vos How to apply: Please complete a University Postgraduate Research Application form and attach at least two references to your application. To complete the application form please visit: www.shef.ac.uk/postgraduate/research/apply. Please clearly state the prospective main supervisor in the respective box and select ‘Neuroscience’ as the department. 'The Medical School has received a Silver Athena SWAN award for promoting gender equality’ Website: http://www.shef.ac.uk/neuroscience Closing date: 3rd February 2014